---
source:
  family: "MDCG"
  title: "md_mdc-2024-16_en"
  path: "02.MDCG/Article 10a – interruption or discontinuation of supply/md_mdc-2024-16_en.pdf"
  pages: 5
  converted: 2026-02-27
  method: pdftotext
---

MDCG 2024 -16 V 1.02
MDCG 2024 – 16
Manufacturer Information Form
on Interruption or Discontinuation of Supply of certain medical devices and certain in vitro
diagnostic medical devices
(as per Article 10a of Regulation (EU) 2024/1860 amending Regulation (EU) 2017/745 and
Regulation (EU) 2017/746)
This document has been endorsed by the Medical Device Coordination Group (MDCG) established by Article 103 of Regulation (EU)
2017/745. The MDCG is composed of representatives of all Member States and it is chaired by a representative of the European
Commission. The document is not a European Commission document and it cannot be regarded as reflecting the official position of the
European Commission. Any views expressed in this document are not legally binding and only the Court of Justice of the European
Union can give binding interpretations of Union law.
Note: this form should be completed where reporting on individual or several devices of the same manufacturer. For reporting on
several devices, only one form should be completed and see section 6 for further instruction. See also Q.11 and Q.12 of 'Q&A
Obligation to inform in case of interruption or discontinuation of supply'. For the purposes of this form, no personal data should be
.submitted or collected, including contact details.
1 Administrative information
Name of National Competent Authority (NCA) to which this report is sent
Type of information

o

Initial information

o

Follow-up information (voluntary)*

o

Additional information (voluntary)*

*Please specify modified sections of the form
(if additional or follow-up information):
Date of information
Reference number assigned by the manufacturer (if any)
Reference number assigned by NCA (as applicable)

2 Information on submitter of the report
Status of submitter

o
o

o

Manufacturer
Authorised Representative (if mandated to act on behalf of the manufacturer)
Other entity (if acting on behalf of the manufacturer)

3 Manufacturer Information
Manufacturer organisation name
Single registration number (if filled here and already EUDAMED registered, please leave following fields in this section 3 open)
Address
Postcode

City

Phone

Fax

E-mail

Country

1

MDCG 2024 -16
4 Authorized Representative Information (if applicable)
Authorised representative organisation name (if mandated to make this report on behalf of the manufacturer)
Single registration number (if filled here and already EUDAMED registered, please leave following fields in this section 4 open)
Address
Postcode

City

Phone

Fax

E-mail

Country

5 Other entity (if applicable)
Organisation (if completing this report on behalf of the manufacturer)
Address
Postcode

City

Phone

Fax

E-mail

Country

2

MDCG 2024 -16
6 Medical device information
Risk class of device
MDD/AIMDD
AIMD Active implant
MDD Class III

IVDD
IVD Annex II List A

MDD Class IIb
MDD Class IIa

IVD Annex II List B
IVD for self-testing

MDD Class I

IVD general

MDD Class I sterile
MDD Class I measuring function
IVDR

MDR

Class D

Class III

Class C

Class IIb
Class IIa

Class B

Class I

Class A
Class A sterile

Class I sterile
Class I measuring function
Class I reusable surgical instruments

Device Identification
Please fill this section when reporting on an individual device.
Where reporting on several devices, complete the ‘MDCG 2024-16 Annex - Device Identification Table’.
Reports on several devices should be for the same manufacturer, the same interruption or discontinuation and same
associated reason (See ‘reasons’ in section 7).
Unique Device Identification (UDI-DI)/EUDAMED ID (if applicable)
Basic UDI-DI/Eudamed-DI (if applicable)
If the above UDI section is completed and the device is already registered in EUDAMED, please leave the following fields blank
and go to ‘Intended use’ field.
If filling out the following fields for devices without UDI-DI/ EUDAMED DI, please complete all mandatory fields.
Model
Catalogue/reference number
Nomenclature system (e.g. EMDN)

Nomenclature code

Nomenclature text
Commercial name/ brand name / proprietary or common name
Intended use according to the IFU or add IFU in attachment (voluntary)

3

MDCG 2024 -16
7 Description of the Interruption or discontinuation of supply (information requested as
per Art 10a)
Specify if the report concerns an interruption or discontinuation
o

Interruption

o

Discontinuation

Reason for the Interruption or Discontinuation of Supply
please select:
Regulatory issue
Supply chain issue
Manufacturing issue
Other
Specify other:

Additional information on reason for the interruption or discontinuation of supply (voluntary)

Information on the assessment of the situation (If available)
Device used in a serious, acute or chronic pathology, life- sustaining or life-saving device or accessory
Intended for a specific population (e.g., vulnerable populations such as paediatric or geriatric patients)
Disruption or interruption limiting / preventing the patients from accessing treatment
Device without or with limited available alternatives, or consumable device not replaceable by any other type/brand
Major market share in one or several members states
Other
Additional information on the assessment of the situation (if available)

Duration
When is the interruption/discontinuation of supply estimated to start?

When is the interruption estimated to end (if available)?
Note: Where the estimated start date differs in case of reporting on several devices, please complete the dedicated field in the
‘MDCG 2024-16 Annex - Device Identification Table’. The same applies for interruptions where end date is provided.
Additional information about the estimated duration, if the start date and the duration is disclosed (voluntary):

Estimated point in time for resumption of supply of the devices (where known and appropriate)

4

MDCG 2024 -16
The medical device is usually marketed and supplied to the following countries: (voluntary)

The countries that are impacted by the interruption/discontinuation:

Information Notification(s) regarding the interruption or discontinuation of supply have been sent:
Notification to HI/HCPS
Notification to AR
Notification to importers
Notification to distributors

Yes
Yes
Yes
Yes

No
No
No
No

Not Applicable
Not Applicable
Not Applicable
Not Applicable

Date Sent (DD/MM/YY)
Date Sent (DD/MM/YY)
Date Sent (DD/MM/YY)
Date Sent (DD/MM/YY)

Attached files (Voluntary)

8 Additional information on Interruption or Discontinuation of Supply (voluntary)

This section allows manufacturer, on voluntary basis or on the request of a competent
authority, to share additional information
Possible mitigations measures: to reduce the impact of the interruption or discontinuation of supply.

Is the redistribution of EU or Global stocks an option?

Yes

No

Do you manufacture a similar alternative product with a similar intended purpose?

Yes

No

Details of the remaining inventory / existing stock level at EU level

If applicable, please provide information in attached file

Progress update on the interruption or discontinuation of supply

5


